Literature DB >> 15340411

When good cholesterol goes bad.

Alan M Fogelman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15340411     DOI: 10.1038/nm0904-902

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  13 in total

1.  Liver receptor homolog 1 is a negative regulator of the hepatic acute-phase response.

Authors:  Nicolas Venteclef; Jason C Smith; Bryan Goodwin; Philippe Delerive
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

Review 2.  HDL therapy for cardiovascular diseases: the road to HDL mimetics.

Authors:  C Roger White; Geeta Datta; Zhenghao Zhang; Himanshu Gupta; David W Garber; Vinod K Mishra; Mayakonda N Palgunachari; Shaila P Handattu; Manjula Chaddha; G M Anantharamaiah
Journal:  Curr Atheroscler Rep       Date:  2008-10       Impact factor: 5.113

3.  High level of serum cholesteryl ester transfer protein in active hepatitis C virus infection.

Authors:  Kenichi Satoh; Tomohisa Nagano; Nobuyoshi Seki; Yoichi Tomita; Yuta Aida; Tomonori Sugita; Munenori Itagaki; Satoshi Sutoh; Hiroshi Abe; Yoshio Aizawa
Journal:  World J Hepatol       Date:  2016-02-18

4.  Coronary artery diseases in South Asian immigrants: an update on high density lipoprotein role in disease prevention.

Authors:  Sunita Dodani
Journal:  J Immigr Minor Health       Date:  2008-09-24

5.  Vasculoprotective Effects of Apolipoprotein Mimetic Peptides: An Evolving Paradigm In Hdl Therapy (Vascular Disease Prevention, In Press.).

Authors:  C Roger White; Geeta Datta; Paulina Mochon; Zhenghao Zhang; Ollie Kelly; Christine Curcio; Dale Parks; Mayakonda Palgunachari; Shaila Handattu; Himanshu Gupta; David W Garber; G M Anantharamaiah
Journal:  Vasc Dis Prev       Date:  2009-01-01

6.  HDL-C and LDL-C: their role in stroke pathogenesis and implications for treatment.

Authors:  Nerses Sanossian; Nicholas E Tarlov
Journal:  Curr Treat Options Cardiovasc Med       Date:  2008-06

7.  A reconstituted HDL containing V156K or R173C apoA-I exhibited anti-inflammatory activity in apo-E deficient mice and showed resistance to myeloperoxidase-mediated oxidation.

Authors:  Kyung Hyun Cho; Jae Ryong Kim
Journal:  Exp Mol Med       Date:  2009-06-30       Impact factor: 8.718

Review 8.  High-density lipoprotein: antioxidant and anti-inflammatory properties.

Authors:  Mohamad Navab; Roger Yu; Nima Gharavi; William Huang; Navid Ezra; Ali Lotfizadeh; G M Anantharamaiah; Nima Alipour; Brian J Van Lenten; Srinivasa T Reddy; Daniel Marelli
Journal:  Curr Atheroscler Rep       Date:  2007-09       Impact factor: 5.113

Review 9.  Lipid metabolism in autoimmune rheumatic disease: implications for modern and conventional therapies.

Authors:  George Robinson; Ines Pineda-Torra; Coziana Ciurtin; Elizabeth C Jury
Journal:  J Clin Invest       Date:  2022-01-18       Impact factor: 14.808

10.  Friend Turns Foe: Transformation of Anti-Inflammatory HDL to Proinflammatory HDL during Acute-Phase Response.

Authors:  Hima Bindu G; Veena S Rao; Vijay V Kakkar
Journal:  Cholesterol       Date:  2010-11-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.